JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Activity
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

94 hedge funds and large institutions have $669M invested in Jounce Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
+11
Holders Change %
+13.25%
% of All Funds
2.16%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
26
Increased
26
Reduced
29
Closed
14
Calls
$21.4M
Puts
$1.58M
Net Calls
+$19.8M
Net Calls Change
+$20M

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$11.7M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$66.4M
3
Citadel Advisors
3
Citadel Advisors
Florida
$6.54M
4
RG
4
Redmile Group
California
$26.4M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$46.3M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$1.86M
2
GPP
2
Great Point Partners
Connecticut
$0
3
PHS
3
PFM Health Sciences
California
$43M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$1.94M
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SG Americas Securities
101
SG Americas Securities
New York
– -$294K -23,079 Closed
Parallax Volatility Advisers
102
Parallax Volatility Advisers
California
– -$28K -2,184 Closed
US Bancorp
103
US Bancorp
Minnesota
– -$18K -1,458 Closed
DCM
104
Delpha Capital Management
New York
– -$11K -824 Closed
Macquarie Group
105
Macquarie Group
Australia
– -$8K -600 Closed
RA
106
Royce & Associates
New York
– -$7K -588 Closed
Group One Trading
107
Group One Trading
Illinois
– -$7K -568 Closed
1 2 3 4
5